Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, Therapeutic insights into the treatment of DM: Tumor suppressor ARF suppresses the expression of an activator of insulin transcription, NeuroD1 via up regulation of its target gene 31/August/2014, 5.23 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at email@example.com.
Significance: This study suggests that ARF, by increasing the expression of its target gene, it may inhibit insulin transcription. Furthermore,this study suggests that pharmacological formulations encompassing “ARF inhibitor” may aid in the treatment of DM.
* Research cooperation